Physician
Vitreo-Retinal Consultants & Surgeons PA
Vitreo-Retinal Consultants & Surgeons PA was paid $1.04M by Medicaid between Jan 2018 and Oct 2024, across 11 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 38% of everything it billed.
33Billing provider infoVITREO-RETINAL CONSULTANTS & SURGEONS PA
WICHITA, KS 67214
WICHITA, KS 67214
33aNPI1275557761assigned 07/27/2006
33bProvider typeOphthalmology Physician
28Total paid$1.04M
24GClaims19,053
24DCodes billed11
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Ophthalmology Physician providers in Kansas
Rank by total paid#1 of 28
Median peer was paid$6K
This provider vs. median179×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,831 | $81K | |
| 2019 | 2,773 | $130K | |
| 2020 | 2,312 | $110K | |
| 2021 | 3,156 | $293K | |
| 2022 | 3,796 | $239K | |
| 2023 | 3,065 | $122K | |
| 2024incomplete | 2,120 | $61K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 38% | 6,261 | 5,340 | $395K |
| J0178 | Injection, aflibercept, 1 mg | 30% | 312 | 258 | $309K |
| J2778 | Injection, ranibizumab, 0.1 mg | 17% | 447 | 361 | $173K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 5.1% | 2,492 | 2,248 | $53K |
| 92134 | 4.4% | 7,097 | 6,256 | $46K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.6% | 1,608 | 1,418 | $27K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.1% | 556 | 365 | $22K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 194 | 175 | $9K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 45 | 42 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 29 | 27 | $1K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 12 | 12 | $356.16 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMAREK, JUDY (PRACTICE ADMINISTRATOR)